213 related articles for article (PubMed ID: 29497118)
1. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein.
Dong D; Guo M; Wang S; Zhu Y; Wang S; Xiong Z; Yang J; Xu Z; Huang Z
Nature; 2017 Jun; 546(7658):436-439. PubMed ID: 28448066
[TBL] [Abstract][Full Text] [Related]
3. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
4. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
5. Disabling Cas9 by an anti-CRISPR DNA mimic.
Shin J; Jiang F; Liu JJ; Bray NL; Rauch BJ; Baik SH; Nogales E; Bondy-Denomy J; Corn JE; Doudna JA
Sci Adv; 2017 Jul; 3(7):e1701620. PubMed ID: 28706995
[TBL] [Abstract][Full Text] [Related]
6. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
[TBL] [Abstract][Full Text] [Related]
7. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
[TBL] [Abstract][Full Text] [Related]
8. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
[TBL] [Abstract][Full Text] [Related]
9. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
[TBL] [Abstract][Full Text] [Related]
10. Conformational plasticity of SpyCas9 induced by AcrIIA4 and AcrIIA2: Insights from molecular dynamics simulation.
Wen S; Zhao Y; Qi X; Cai M; Huang K; Liu H; Kong DX
Comput Struct Biotechnol J; 2024 Dec; 23():537-548. PubMed ID: 38235361
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
[TBL] [Abstract][Full Text] [Related]
12. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the anti-CRISPR, AcrIIC4.
Kim GE; Lee SY; Park HH
Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
[TBL] [Abstract][Full Text] [Related]
14. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Apr; 164(4):464-474. PubMed ID: 29488867
[TBL] [Abstract][Full Text] [Related]
15. Differential Divalent Metal Binding by SpyCas9's RuvC Active Site Contributes to Nonspecific DNA Cleavage.
Newsom SN; Wang DS; Rostami S; Schuster I; Parameshwaran HP; Joseph YG; Qin PZ; Liu J; Rajan R
CRISPR J; 2023 Dec; 6(6):527-542. PubMed ID: 38108519
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
17. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
18. Critical Anti-CRISPR Locus Repression by a Bi-functional Cas9 Inhibitor.
Osuna BA; Karambelkar S; Mahendra C; Sarbach A; Johnson MC; Kilcher S; Bondy-Denomy J
Cell Host Microbe; 2020 Jul; 28(1):23-30.e5. PubMed ID: 32325051
[TBL] [Abstract][Full Text] [Related]
19. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects.
Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J
J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
